Managlinat dialanetil is an orally bioavailable inhibitor of fructose 1,6-bisphosphatase (FBPase). It is used for the treatment of type 2 diabetes.

After oral administration, in Zucker diabetic fatty (ZDF) rats, Managlinat dialanetil dose-dependently inhibits GNG as well as lower basal and postprandial blood glucose levels[1].

280782-97-0

C21H33N4O6PS

500.55

CS-917;MB06322

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years